Episodes
Thursday Mar 31, 2022
TJ Cradick Speaks About Their HIV CRISPR Therapy in Trials
Thursday Mar 31, 2022
Thursday Mar 31, 2022
TJ Cradick, Chief Scientific Officer at Excision Bio, discusses their CRISPR HIV therapy that recently proceeded into clinical trials in this episode and their ongoing work on other viral diseases.
Version: 20240320